Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis

Por Purohit, Vivek, Riley, Steve, Tan, Huaming, Ports, William C.
Publicado no J Clin Pharmacol (2020)

Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data

Por Armstrong, April W., Koning, J. Will, Rowse, Simon, Tan, Huaming, Mamolo, Carla, Kaur, Mandeep
Publicado no Dermatol Ther (Heidelb) (2016)

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis

Por Xin, Xiaoyan, Zeng, Xianqin, Gu, Huajian, Li, Min, Tan, Huaming, Jin, Zhishan, Hua, Teng, Shi, Rui, Wang, Hongbo
Publicado no Sci Rep (2016)

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis

Por Valenzuela, Fernando, Papp, Kim A, Pariser, David, Tyring, Stephen K, Wolk, Robert, Buonanno, Marjorie, Wang, Jeff, Tan, Huaming, Valdez, Hernan
Publicado no BMC Dermatol (2015)

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

Por Callender, Valerie D., Alexis, Andrew F., Stein Gold, Linda F., Lebwohl, Mark G., Paller, Amy S., Desai, Seemal R., Tan, Huaming, Ports, William C., Zielinski, Michael A., Tallman, Anna M.
Publicado no Am J Clin Dermatol (2019)